Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | nephroblastoma | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:28825729 | |
|
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | nephroblastoma | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:28825729 | |
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | The super elongation complex (SEC) family in transcriptional control. | Luo Z, etal., Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7. doi: 10.1038/nrm3417. Epub 2012 Aug 16. |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
4. | RGD HPO Phenotype Annotation Pipeline | RGD automated import pipeline for human HPO-to-gene-to-disease annotations |
MLLT1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mllt1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mllt1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mllt1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MLLT1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MLLT1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mllt1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MLLT1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MLLT1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mllt1 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in MLLT1
18 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 19p13.3-13.2(chr19:1972245-9648879)x3 | copy number gain | See cases [RCV000052879] | Chr19:1972245..9648879 [GRCh38] Chr19:1972244..9759555 [GRCh37] Chr19:1923244..9620555 [NCBI36] Chr19:19p13.3-13.2 |
pathogenic |
GRCh38/hg38 19p13.3-13.2(chr19:4039158-9176125)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052881]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052881]|See cases [RCV000052881] | Chr19:4039158..9176125 [GRCh38] Chr19:4039156..9286801 [GRCh37] Chr19:3990156..9147801 [NCBI36] Chr19:19p13.3-13.2 |
pathogenic |
GRCh38/hg38 19p13.3(chr19:4934885-6501642)x3 | copy number gain | See cases [RCV000052882] | Chr19:4934885..6501642 [GRCh38] Chr19:4934897..6501653 [GRCh37] Chr19:4885897..6452653 [NCBI36] Chr19:19p13.3 |
pathogenic |
GRCh38/hg38 19p13.3-13.2(chr19:265917-8564134)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052876]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052876]|See cases [RCV000052876] | Chr19:265917..8564134 [GRCh38] Chr19:265917..8629018 [GRCh37] Chr19:216917..8535018 [NCBI36] Chr19:19p13.3-13.2 |
pathogenic |
GRCh38/hg38 19p13.3-13.2(chr19:5905175-6916287)x3 | copy number gain | See cases [RCV000139338] | Chr19:5905175..6916287 [GRCh38] Chr19:5905186..6916298 [GRCh37] Chr19:5856186..6867298 [NCBI36] Chr19:19p13.3-13.2 |
uncertain significance |
GRCh38/hg38 19p13.3(chr19:259395-6795611)x3 | copy number gain | See cases [RCV000142627] | Chr19:259395..6795611 [GRCh38] Chr19:259395..6795622 [GRCh37] Chr19:210395..6746622 [NCBI36] Chr19:19p13.3 |
pathogenic |
NM_005934.4(MLLT1):c.1418G>A (p.Arg473Gln) | single nucleotide variant | Hypertelorism [RCV000491445] | Chr19:6213787 [GRCh38] Chr19:6213798 [GRCh37] Chr19:19p13.3 |
likely pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888) | copy number gain | See cases [RCV000512296] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3 | copy number gain | See cases [RCV000511289] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic|uncertain significance |
GRCh37/hg19 19p13.3-13.2(chr19:3120160-9732820)x3 | copy number gain | not provided [RCV000684096] | Chr19:3120160..9732820 [GRCh37] Chr19:19p13.3-13.2 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-59097160)x3 | copy number gain | not provided [RCV000752444] | Chr19:260912..59097160 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:68029-59110290)x3 | copy number gain | not provided [RCV000752439] | Chr19:68029..59110290 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_005934.4(MLLT1):c.689C>T (p.Ser230Leu) | single nucleotide variant | not provided [RCV000891629] | Chr19:6222542 [GRCh38] Chr19:6222553 [GRCh37] Chr19:19p13.3 |
benign |
GRCh37/hg19 19p13.3(chr19:5949772-6699729)x3 | copy number gain | not provided [RCV001007028] | Chr19:5949772..6699729 [GRCh37] Chr19:19p13.3 |
uncertain significance |
GRCh37/hg19 19p13.3(chr19:6246138-6823741)x3 | copy number gain | not provided [RCV001007029] | Chr19:6246138..6823741 [GRCh37] Chr19:19p13.3 |
uncertain significance |
GRCh37/hg19 19p13.3(chr19:6096399-6699729)x3 | copy number gain | not provided [RCV001259930] | Chr19:6096399..6699729 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1630G>A (p.Glu544Lys) | single nucleotide variant | not specified [RCV004320488] | Chr19:6213092 [GRCh38] Chr19:6213103 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1345G>A (p.Asp449Asn) | single nucleotide variant | not specified [RCV004200788] | Chr19:6214001 [GRCh38] Chr19:6214012 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.938G>C (p.Gly313Ala) | single nucleotide variant | not specified [RCV004212467] | Chr19:6222293 [GRCh38] Chr19:6222304 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1057G>A (p.Ala353Thr) | single nucleotide variant | not specified [RCV004102587] | Chr19:6222174 [GRCh38] Chr19:6222185 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1364G>A (p.Arg455His) | single nucleotide variant | not specified [RCV004275318] | Chr19:6213982 [GRCh38] Chr19:6213993 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.469G>A (p.Asp157Asn) | single nucleotide variant | not specified [RCV004325935] | Chr19:6227054 [GRCh38] Chr19:6227065 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.925C>T (p.Arg309Trp) | single nucleotide variant | not specified [RCV004357944] | Chr19:6222306 [GRCh38] Chr19:6222317 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.886A>G (p.Ser296Gly) | single nucleotide variant | not specified [RCV004361613] | Chr19:6222345 [GRCh38] Chr19:6222356 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.449C>A (p.Thr150Lys) | single nucleotide variant | not specified [RCV004365442] | Chr19:6227074 [GRCh38] Chr19:6227085 [GRCh37] Chr19:19p13.3 |
uncertain significance |
GRCh37/hg19 19p13.3-13.2(chr19:260912-7246777)x3 | copy number gain | not provided [RCV003485190] | Chr19:260912..7246777 [GRCh37] Chr19:19p13.3-13.2 |
pathogenic |
NM_005934.4(MLLT1):c.1643G>A (p.Arg548His) | single nucleotide variant | not provided [RCV003421771] | Chr19:6213079 [GRCh38] Chr19:6213090 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1103A>C (p.Lys368Thr) | single nucleotide variant | not specified [RCV004499088] | Chr19:6222128 [GRCh38] Chr19:6222139 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.554A>G (p.Asn185Ser) | single nucleotide variant | not specified [RCV004499320] | Chr19:6222677 [GRCh38] Chr19:6222688 [GRCh37] Chr19:19p13.3 |
likely benign |
NM_005934.4(MLLT1):c.1460A>G (p.Lys487Arg) | single nucleotide variant | not specified [RCV004499226] | Chr19:6213745 [GRCh38] Chr19:6213756 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.860C>T (p.Pro287Leu) | single nucleotide variant | not specified [RCV004499352] | Chr19:6222371 [GRCh38] Chr19:6222382 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.1426C>T (p.Pro476Ser) | single nucleotide variant | not specified [RCV004499196] | Chr19:6213779 [GRCh38] Chr19:6213790 [GRCh37] Chr19:19p13.3 |
uncertain significance |
NM_005934.4(MLLT1):c.974C>T (p.Ser325Leu) | single nucleotide variant | not specified [RCV004501458] | Chr19:6222257 [GRCh38] Chr19:6222268 [GRCh37] Chr19:19p13.3 |
uncertain significance |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
WI-20279 |
|
||||||||||||||||||||||||||||||||||||||||
UniSTS:486265 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | visual system | adipose tissue | appendage | entire extraembryonic component | pharyngeal arch | |
High | ||||||||||||||||||
Medium | 2428 | 2816 | 1641 | 545 | 1832 | 387 | 4348 | 2111 | 3668 | 361 | 1427 | 1598 | 171 | 1204 | 2781 | 4 | ||
Low | 11 | 175 | 85 | 79 | 116 | 78 | 9 | 86 | 66 | 57 | 33 | 15 | 4 | 1 | 7 | 2 | 2 | |
Below cutoff | 2 | 1 |
RefSeq Acc Id: | ENST00000252674 ⟹ ENSP00000252674 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000585588 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000587473 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_005934 ⟹ NP_005925 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_011528021 ⟹ XP_011526323 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_011528022 ⟹ XP_011526324 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_011528023 ⟹ XP_011526325 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_017026819 ⟹ XP_016882308 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_047438846 ⟹ XP_047294802 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054321042 ⟹ XP_054177017 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054321043 ⟹ XP_054177018 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054321044 ⟹ XP_054177019 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054321045 ⟹ XP_054177020 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054321046 ⟹ XP_054177021 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_005925 ⟸ NM_005934 |
- UniProtKB: | Q14768 (UniProtKB/Swiss-Prot), Q03111 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | XP_011526325 ⟸ XM_011528023 |
- Peptide Label: | isoform X3 |
- Sequence: |
RefSeq Acc Id: | XP_011526323 ⟸ XM_011528021 |
- Peptide Label: | isoform X1 |
- Sequence: |
RefSeq Acc Id: | XP_011526324 ⟸ XM_011528022 |
- Peptide Label: | isoform X2 |
- Sequence: |
RefSeq Acc Id: | XP_016882308 ⟸ XM_017026819 |
- Peptide Label: | isoform X4 |
- Sequence: |
RefSeq Acc Id: | ENSP00000252674 ⟸ ENST00000252674 |
RefSeq Acc Id: | XP_047294802 ⟸ XM_047438846 |
- Peptide Label: | isoform X5 |
RefSeq Acc Id: | XP_054177021 ⟸ XM_054321046 |
- Peptide Label: | isoform X5 |
RefSeq Acc Id: | XP_054177019 ⟸ XM_054321044 |
- Peptide Label: | isoform X3 |
RefSeq Acc Id: | XP_054177017 ⟸ XM_054321042 |
- Peptide Label: | isoform X1 |
RefSeq Acc Id: | XP_054177018 ⟸ XM_054321043 |
- Peptide Label: | isoform X2 |
RefSeq Acc Id: | XP_054177020 ⟸ XM_054321045 |
- Peptide Label: | isoform X4 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q03111-F1-model_v2 | AlphaFold | Q03111 | 1-559 | view protein structure |
RGD ID: | 6795810 | ||||||||
Promoter ID: | HG_KWN:28644 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | NM_005934 | ||||||||
Position: |
|
RGD ID: | 7238199 | ||||||||
Promoter ID: | EPDNEW_H24845 | ||||||||
Type: | initiation region | ||||||||
Name: | MLLT1_1 | ||||||||
Description: | MLLT1, super elongation complex subunit | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:7134 | AgrOrtholog |
COSMIC | MLLT1 | COSMIC |
Ensembl Genes | ENSG00000130382 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000252674 | ENTREZGENE |
ENST00000252674.9 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 1.20.1270.290 | UniProtKB/Swiss-Prot |
2.60.40.1970 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000130382 | GTEx |
HGNC ID | HGNC:7134 | ENTREZGENE |
Human Proteome Map | MLLT1 | Human Proteome Map |
InterPro | AF-9_AHD | UniProtKB/Swiss-Prot |
YEAST_sf | UniProtKB/Swiss-Prot | |
YEATS | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:4298 | UniProtKB/Swiss-Prot |
NCBI Gene | 4298 | ENTREZGENE |
OMIM | 159556 | OMIM |
PANTHER | AHD DOMAIN-CONTAINING PROTEIN | UniProtKB/Swiss-Prot |
PROTEIN ENL | UniProtKB/Swiss-Prot | |
Pfam | AHD | UniProtKB/Swiss-Prot |
YEATS | UniProtKB/Swiss-Prot | |
PharmGKB | PA30848 | PharmGKB |
PROSITE | YEATS | UniProtKB/Swiss-Prot |
UniProt | ENL_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE |
Q14768 | ENTREZGENE | |
UniProt Secondary | Q14768 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2019-01-29 | MLLT1 | MLLT1 super elongation complex subunit | MLLT1, super elongation complex subunit | Symbol and/or name change | 5135510 | APPROVED | |
2016-06-21 | MLLT1 | MLLT1, super elongation complex subunit | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 | Symbol and/or name change | 5135510 | APPROVED | |
2015-06-30 | MLLT1 | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | Symbol and/or name change | 5135510 | APPROVED |